• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新发单基因神经发育障碍疾病的 de novo 变异发生率目录。

A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants.

机构信息

Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, USA.

Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, USA.

出版信息

Brain. 2020 Apr 1;143(4):1099-1105. doi: 10.1093/brain/awaa051.

DOI:10.1093/brain/awaa051
PMID:32168371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7174049/
Abstract

A large fraction of rare and severe neurodevelopmental disorders are caused by sporadic de novo variants. Epidemiological disease estimates are not available for the vast majority of these de novo monogenic neurodevelopmental disorders because of phenotypic heterogeneity and the absence of large-scale genomic screens. Yet, knowledge of disease incidence is important for clinicians and researchers to guide health policy planning. Here, we adjusted a statistical method based on genetic data to predict, for the first time, the incidences of 101 known de novo variant-associated neurodevelopmental disorders as well as 3106 putative monogenic disorders. Two corroboration analyses supported the validity of the calculated estimates. First, greater predicted gene-disorder incidences positively correlated with larger numbers of pathogenic variants collected from patient variant databases (Kendall's τ = 0.093, P-value = 6.9 × 10-6). Second, for six of seven (86%) de novo variant associated monogenic disorders for which epidemiological estimates were available (SCN1A, SLC2A1, SALL1, TBX5, KCNQ2, and CDKL5), the predicted incidence estimates matched the reported estimates. We conclude that in the absence of epidemiological data, our catalogue of 3207 incidence estimates for disorders caused by de novo variants can guide patient advocacy groups, clinicians, researchers, and policymakers in strategic decision-making.

摘要

大量罕见且严重的神经发育障碍是由散发性新生变异引起的。由于表型异质性和缺乏大规模基因组筛查,绝大多数新生单基因神经发育障碍疾病都没有流行病学疾病估计值。然而,疾病发病率的知识对于指导临床医生和研究人员制定卫生政策规划非常重要。在这里,我们调整了一种基于遗传数据的统计方法,首次预测了 101 种已知新生变异相关神经发育障碍和 3106 种推定单基因疾病的发病率。两项验证分析支持了计算出的估计值的有效性。首先,更多预测的基因-疾病发病率与从患者变异数据库中收集的致病性变异数量呈正相关(Kendall's τ=0.093,P 值=6.9×10-6)。其次,对于六种(86%)已知具有流行病学估计值的新生变异相关单基因疾病(SCN1A、SLC2A1、SALL1、TBX5、KCNQ2 和 CDKL5),预测的发病率估计值与报告的估计值相符。我们的结论是,在没有流行病学数据的情况下,我们的 3207 种由新生变异引起的疾病的发病率估计目录可以为患者权益团体、临床医生、研究人员和政策制定者在战略决策中提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a05/7174049/3a186f09de01/awaa051f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a05/7174049/3a186f09de01/awaa051f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a05/7174049/3a186f09de01/awaa051f1.jpg

相似文献

1
A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants.新发单基因神经发育障碍疾病的 de novo 变异发生率目录。
Brain. 2020 Apr 1;143(4):1099-1105. doi: 10.1093/brain/awaa051.
2
Common genetic variants contribute to risk of rare severe neurodevelopmental disorders.常见遗传变异与罕见严重神经发育障碍风险相关。
Nature. 2018 Oct;562(7726):268-271. doi: 10.1038/s41586-018-0566-4. Epub 2018 Sep 26.
3
De novo variants in neurodevelopmental disorders-experiences from a tertiary care center.神经发育障碍中的新生变异——来自三级医疗中心的经验
Clin Genet. 2021 Jul;100(1):14-28. doi: 10.1111/cge.13946. Epub 2021 Mar 1.
4
Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.通过对单核苷酸变异和拷贝数变异的统一分析,大规模发现新的神经发育障碍相关基因。
Genome Med. 2022 Apr 26;14(1):40. doi: 10.1186/s13073-022-01042-w.
5
Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.通过使用群体参考样本优化新生蛋白质截短变异体在神经发育障碍中的作用。
Nat Genet. 2017 Apr;49(4):504-510. doi: 10.1038/ng.3789. Epub 2017 Feb 13.
6
Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies.通过大型队列研究估算新发单基因神经发育障碍的患病率。
Biomedicines. 2022 Nov 9;10(11):2865. doi: 10.3390/biomedicines10112865.
7
Genomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland.英国和爱尔兰罕见儿科疾病的基因组诊断。
N Engl J Med. 2023 Apr 27;388(17):1559-1571. doi: 10.1056/NEJMoa2209046. Epub 2023 Apr 12.
8
Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.神经发育障碍中的变异再现:利用公开可用的基因组数据鉴定具有临床相关性的致病性错义变异。
Genet Med. 2019 Nov;21(11):2504-2511. doi: 10.1038/s41436-019-0518-x. Epub 2019 Apr 30.
9
Parental mosaicism in de novo neurodevelopmental diseases.新发神经发育疾病中的亲代镶嵌现象。
Am J Med Genet A. 2021 Jul;185(7):2119-2125. doi: 10.1002/ajmg.a.62174. Epub 2021 Apr 14.
10
Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.70 个基因在 8565 例癫痫和神经发育障碍患者中的基因检测诊断结果。
Epilepsia. 2018 May;59(5):1062-1071. doi: 10.1111/epi.14074. Epub 2018 Apr 14.

引用本文的文献

1
RNA -splicing to rescue β-catenin: A novel approach for treating CTNNB1-Haploinsufficiency disorder.通过RNA剪接挽救β-连环蛋白:一种治疗CTNNB1单倍体不足症的新方法。
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102680. doi: 10.1016/j.omtn.2025.102680. eCollection 2025 Sep 9.
2
Genotypic, functional, and phenotypic characterization in CTNNB1 neurodevelopmental syndrome.CTNNB1神经发育综合征的基因型、功能和表型特征
HGG Adv. 2025 Jul 18;6(4):100483. doi: 10.1016/j.xhgg.2025.100483.
3
OCNDS core features are conserved across variants, with loop-region mutations driving greater symptom burden.

本文引用的文献

1
Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3.MARCH6 中的不稳定 TTTTA/TTTCA 扩展与家族性成年肌阵挛性癫痫 3 型有关。
Nat Commun. 2019 Oct 29;10(1):4919. doi: 10.1038/s41467-019-12763-9.
2
TTTCA repeat insertions in an intron of YEATS2 in benign adult familial myoclonic epilepsy type 4.TTTCA 重复插入 YEATS2 基因的内含子中与良性家族性婴儿惊厥 4 型相关。
Brain. 2019 Nov 1;142(11):3360-3366. doi: 10.1093/brain/awz267.
3
Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy.
OCNDS的核心特征在不同变体中是保守的,环区突变导致更重的症状负担。
Front Hum Neurosci. 2025 Jul 3;19:1589897. doi: 10.3389/fnhum.2025.1589897. eCollection 2025.
4
Characterizing healthcare resource utilization in two rare diseases (Kleefstra syndrome and SLC6A1 epileptic encephalopathy) using multimodal real-world data.利用多模态真实世界数据对两种罕见疾病(克莱夫斯特拉综合征和SLC6A1癫痫性脑病)的医疗资源利用情况进行特征分析。
Orphanet J Rare Dis. 2025 Jul 7;20(1):344. doi: 10.1186/s13023-025-03879-x.
5
Functional defects in FOXG1 variants predict the severity of brain anomalies in FOXG1 syndrome.FOXG1 变体的功能缺陷预示着 FOXG1 综合征中脑异常的严重程度。
Mol Psychiatry. 2025 Jun 16. doi: 10.1038/s41380-025-03077-y.
6
Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy.家族性SYNGAP1基因变异确定了一种伴有癫痫的复杂神经发育障碍的界限。
Epilepsia. 2025 May 23. doi: 10.1111/epi.18469.
7
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy.羊膜腔内反义寡核苷酸治疗可改善脊髓性肌萎缩症临床前模型中的表型。
Sci Transl Med. 2025 May 14;17(798):eadv4656. doi: 10.1126/scitranslmed.adv4656.
8
Overgrowth-intellectual disability disorders: progress in biology, patient advocacy and innovative therapies.过度生长-智力障碍疾病:生物学、患者权益倡导及创新疗法的进展
Dis Model Mech. 2025 May 1;18(5). doi: 10.1242/dmm.052300. Epub 2025 May 12.
9
Molecular and clinical aspects of histone-related disorders.组蛋白相关疾病的分子与临床研究进展
Hum Genomics. 2025 Apr 29;19(1):47. doi: 10.1186/s40246-025-00734-9.
10
Quantitative Phenotype Morbidity Description of -Associated Syndrome.与 - 相关综合征的定量表型发病率描述。
Hum Mutat. 2023 Apr 26;2023:8200176. doi: 10.1155/2023/8200176. eCollection 2023.
在一个患有儿童癫痫的大型队列中,通过联合检测序列和基因内拷贝数变异进行基因检测可能对精准医学产生的影响。
Epilepsia Open. 2019 Jul 1;4(3):397-408. doi: 10.1002/epi4.12348. eCollection 2019 Sep.
4
Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.儿童起病遗传性癫痫的发病率和表型:一项前瞻性基于人群的全国队列研究。
Brain. 2019 Aug 1;142(8):2303-2318. doi: 10.1093/brain/awz195.
5
Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies.异常内含一个毒性外显子导致德拉维特综合征和相关 SCN1A 相关遗传性癫痫。
Am J Hum Genet. 2018 Dec 6;103(6):1022-1029. doi: 10.1016/j.ajhg.2018.10.023.
6
TTTCA repeat expansion causes familial cortical myoclonic tremor with epilepsy.TTTCA 重复扩展导致家族性皮质肌阵挛性震颤伴癫痫。
Eur J Neurol. 2019 Mar;26(3):513-518. doi: 10.1111/ene.13848. Epub 2018 Nov 30.
7
De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus.人类先天性脑积水相关基因调控神经干细胞命运的新生突变。
Neuron. 2018 Jul 25;99(2):302-314.e4. doi: 10.1016/j.neuron.2018.06.019. Epub 2018 Jul 5.
8
De novo variants in neurodevelopmental disorders with epilepsy.神经发育障碍伴癫痫的从头变异。
Nat Genet. 2018 Jul;50(7):1048-1053. doi: 10.1038/s41588-018-0143-7. Epub 2018 Jun 25.
9
Prevalence and properties of intragenic copy-number variation in Mendelian disease genes.孟德尔疾病基因中基因内拷贝数变异的流行率和特征。
Genet Med. 2019 Jan;21(1):114-123. doi: 10.1038/s41436-018-0033-5. Epub 2018 Jun 12.
10
The Problem of Rarity: Estimation of Prevalence in Rare Disease.罕见病问题:患病率估计。
Value Health. 2018 May;21(5):501-507. doi: 10.1016/j.jval.2018.03.002. Epub 2018 Apr 5.